• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT Back to Search Results
Lot Number 0030944954
Medical Device Problem Codes Material Rupture (1546); Device Dislodged or Dislocated (2923)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/19/2024
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that the stent dislodged inside the patient requiring additional intervention.The target lesion was located in the middle of the left anterior descending (lad) artery.A 3.00 x 8mm synergy xd drug-eluting stent was used for treatment.Prior to inflation, the stent came off the balloon.When the balloon was inflated to securely deploy the stent inside another stent, the balloon ruptured.A new stent was inserted to complete the procedure.No patient complications were reported.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: synergy xd mr us 3.00 x 8mm stent delivery system, catheter was returned for analysis.Visual, tactile, microscopic and functional analysis was performed on the device.Visual and tactile inspection identified no issues with the hypotube shaft, no issues were identified with the outer / mid-shaft sections or the inner lumen of the device, and no stent was attached to the balloon.Microscopic analysis revealed the balloon was subjected to positive pressure and the bumper tip showed no signs of distal tip damage.Functional analysis was performed, the device was attached to an inflation unit and the balloon was inflated to its rated burst pressure per the instructions for use.No other device issues were identified during returned product analysis.
 
Event or Problem Description
It was reported that the stent dislodged inside the patient requiring additional intervention.The target lesion was located in the middle of the left anterior descending (lad) artery.A 3.00 x 8mm synergy xd drug-eluting stent was used for treatment.Prior to inflation, the stent came off the balloon.When the balloon was inflated to securely deploy the stent inside another stent, the balloon ruptured.A new stent was inserted to complete the procedure.No patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY XD
Common Device Name
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18681731
Report Number2124215-2024-04069
Device Sequence Number6155869
Product Code NIQ
UDI-Device Identifier08714729980940
UDI-Public08714729980940
Combination Product (Y/N)Y
Initial Reporter StateTX
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/01/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/22/2025
Device Lot Number0030944954
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 01/19/2024
Supplement Date Received by Manufacturer03/08/2024
Initial Report FDA Received Date02/09/2024
Supplement Report FDA Received Date04/01/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured01/23/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-